Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07106372
PHASE3
A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
Sponsor: Keymed Biosciences Co.Ltd
View on ClinicalTrials.gov
Summary
This is a multi-center, single-arm, open-label phase 3 study to evaluate the safety, efficacy, Pharmacokinetics(PK) and immunogenicity of Stapokibatrt in children with Atopic Dermatitis.
Official title: A Multi-center, Single-arm, Open-label Study to Evaluate the Safety and Efficacy of Stapokibatrt in Children With Atopic Dermatitis
Key Details
Gender
All
Age Range
2 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
240
Start Date
2025-09
Completion Date
2027-06
Last Updated
2025-08-06
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
Stapokibatrt
Stapokibatrt Subcutaneous injection
Locations (1)
Beijing Children's Hospital Capital Medical University
Beijing, Beijing Municipality, China